pI: 6.62 |
Length (AA): 7194 |
MW (Da): 626431 |
Paralog Number:
4
Signal peptide: Y | GPI Anchor: N | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
There are 14 models calculated for this protein. More info on
these models, including the
models themselves is available at:
Modbase
Target Beg | Target End | Template | Template Beg | Template End | Identity | Evalue | Model Score | MPQS | zDope |
---|---|---|---|---|---|---|---|---|---|
201 | 292 | 1ogq (A) | 83 | 175 | 35.00 | 0.000000059 | 0.99 | 0.55 | -1.26 |
6986 | 7194 | 1ogq (A) | 5 | 311 | 23.00 | 0 | 1 | -0.34 | 0.26 |
7081 | 7191 | 1dce (A) | 463 | 567 | 22.00 | 0 | 0.69 | 0.27 | -0.97 |
126 | 276 | 4u08 (A) | 209 | 358 | 27.00 | 0.00065 | 1 | 0.41249 | -0.89 |
128 | 284 | 4qxf (A) | 47 | 265 | 34.00 | 0.021 | 0.51 | -0.124676 | 0.9 |
201 | 292 | 1ogq (A) | 83 | 175 | 35.00 | 0.000000084 | 0.99 | 0.534288 | -1.1 |
834 | 949 | 3s6l (A) | 13 | 132 | 33.00 | 0.000055 | 0.13 | 0.271625 | 0.1 |
2389 | 2482 | 1oqy (A) | 77 | 161 | 38.00 | 0.00015 | 0 | 0.137566 | 1.28 |
3682 | 3801 | 2k3o (A) | 2 | 121 | 32.00 | 0.00029 | 0.21 | 0.306181 | 0.24 |
5867 | 6023 | 2k3n (A) | 3 | 162 | 31.00 | 0.000000019 | 0.03 | 0.204324 | 0.93 |
6891 | 7050 | 1g66 (A) | 10 | 181 | 28.00 | 0.93 | 0.26 | 0.0777408 | 0.63 |
6990 | 7177 | 4z5w (A) | 31 | 230 | 30.00 | 0.00000045 | 1 | 0.298633 | -0.6 |
7066 | 7172 | 5gr9 (B) | 210 | 317 | 38.00 | 0.000000000006 | 1 | 0.582373 | -1.15 |
7100 | 7165 | 4u06 (A) | 156 | 219 | 41.00 | 0.0023 | 0.97 | 0.541674 | -0.83 |
Help me make sense of these data.
A more detailed description of these scores is available at the Modbase Model Evaluation Help Pages, and in the papers referenced therein.
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Lower 0-20% percentile | amastigotes, metacyclic. | Fernandes MC |
Fernandes MC | Dual Transcriptome Profiling of Leishmania-Infected Human Macrophages Reveals Distinct Reprogramming Signatures. |
Ortholog group members (OG5_126579)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G12145 | leucine-rich repeat protein FLOR1 |
Arabidopsis thaliana | AT4G18600 | SCAR family protein WAVE5 |
Babesia bovis | BBOV_IV000140 | hypothetical protein |
Babesia bovis | BBOV_IV003650 | hypothetical protein |
Babesia bovis | BBOV_IV004080 | membrane protein, putative |
Brugia malayi | Bm1_40520 | Lectin C-type domain containing protein |
Brugia malayi | Bm1_43885 | PAN domain containing protein |
Brugia malayi | Bm1_06695 | hypothetical protein |
Candida albicans | CaO19.79 | similar to internal repeat region of ALS4 (AAG25054), ALS3 (AAC39486), ALS1 (AAC41649), etc. |
Candida albicans | CaO19.7400 | agglutinin-like protein |
Candida albicans | CaO19.8979 | Enhanced Adherence to Polystyrene |
Candida albicans | CaO19.1490 | similar to S. cerevisiae MUC1 (YIR019C) cell surface flocculin |
Candida albicans | CaO19.5736 | agglutinin-like protein |
Candida albicans | CaO19.13163 | agglutinin-like protein |
Candida albicans | CaO19.13168 | best match to 5' end of 3' partial cds for ALS9 (AAK00765) |
Candida albicans | CaO19.10888 | potential hyphal form cell wall protein similar to S. cerevisiae MUC1 (YIR019C) cell surface flocculin |
Candida albicans | CaO19.1098 | almost identical to ALS2-1 allele 3' partial cds (AAC64236) |
Candida albicans | CaO19.9183 | low complexity, reptitive protein similar to cell surface flocculin-like protein |
Candida albicans | CaO19.1616 | low complexity, reptitive protein similar to cell surface flocculin-like protein |
Candida albicans | CaO19.4075 | low complexity orf |
Candida albicans | CaO19.45 | agglutinin-like protein |
Candida albicans | CaO19.3380 | potential hyphal form cell wall protein similar to S. cerevisiae MUC1 (YIR019C) cell surface flocculin |
Candida albicans | CaO19.9670 | likely frameshifted C terminus of ALS4-like CaP19.9669 |
Candida albicans | CaO19.5745 | best match to 5' end of 3' partial cds for ALS9 (AAK00765) |
Candida albicans | CaO19.9067 | similar to S. cerevisiae MUC1 (YIR019C) cell surface flocculin |
Candida albicans | CaO19.2355 | agglutinin-like protein |
Candida albicans | CaO19.13166 | consists of 13 repeats of MVVVLANDSDQNSVVVTVGLCGSLTMTEFVPSGGLV |
Candida albicans | CaO19.13158 | agglutinin-like protein |
Candida albicans | CaO19.9891 | agglutinin-like protein |
Candida albicans | CaO19.8700 | almost identical to ALS2-1 allele 3' partial cds (AAC64236) up to end of contig |
Candida albicans | CaO19.2122 | likely frameshifted C terminus of ALS4-like CaP19.2121 |
Candida albicans | CaO19.9669 | DNA similarity to ALS4-like sequence (AAG25054) continues to 5' end of contig and past stop codon of this orf, frameshifts to Ca |
Candida albicans | CaO19.5741 | agglutinin-like protein |
Candida albicans | CaO19.4556 | very good match to ALS4-2, 3' partial cds (AAC64242) |
Candida albicans | CaO19.7414 | agglutinin-like protein almost identical to ALS6 (AAO72081) |
Candida albicans | CaO19.2121 | DNA similarity to ALS4-like sequence (AAG25054) continues to 5' end of contig and past stop codon of this orf, frameshifts to Ca |
Candida albicans | CaO19.1401 | Enhanced Adherence to Polystyrene |
Caenorhabditis elegans | CELE_C03E10.5 | Protein CLEC-223 |
Caenorhabditis elegans | CELE_H02F09.3 | Protein H02F09.3 |
Caenorhabditis elegans | CELE_ZC178.2 | Protein ZC178.2 |
Caenorhabditis elegans | CELE_F16F9.2 | Protein DPY-6 |
Caenorhabditis elegans | CELE_T06D8.1 | Protein SRAP-1, isoform A |
Caenorhabditis elegans | CELE_H43E16.1 | Protein H43E16.1 |
Cryptosporidium hominis | Chro.20329 | hypothetical protein |
Cryptosporidium parvum | cgd2_3130 | hypothetical protein with possible transcriptional repressor EZH1 domain |
Cryptosporidium parvum | cgd4_3630 | conserved hypothetical protein |
Dictyostelium discoideum | DDB_G0287863 | hypothetical protein |
Dictyostelium discoideum | DDB_G0283585 | hypothetical protein |
Dictyostelium discoideum | DDB_G0302588 | RanBP2-type zinc finger |
Dictyostelium discoideum | DDB_G0285923 | hypothetical protein |
Dictyostelium discoideum | DDB_G0274915 | hypothetical protein |
Dictyostelium discoideum | DDB_G0290651 | hypothetical protein |
Dictyostelium discoideum | DDB_G0295727 | hypothetical protein |
Drosophila melanogaster | Dmel_CG4090 | Mucin related 89F |
Drosophila melanogaster | Dmel_CG7002 | Hemolectin |
Drosophila melanogaster | Dmel_CG33196 | dumpy |
Drosophila melanogaster | Dmel_CG33265 | Mucin 68E |
Drosophila melanogaster | Dmel_CG33300 | Mucin 30E |
Drosophila melanogaster | Dmel_CG18331 | Mucin 68Ca |
Drosophila melanogaster | Dmel_CG32580 | Mucin 14A |
Drosophila melanogaster | Dmel_CG14796 | Mucin related 2B |
Drosophila melanogaster | Dmel_CG32602 | Mucin 12Ea |
Drosophila melanogaster | Dmel_CG3047 | Salivary gland secretion 1 |
Drosophila melanogaster | Dmel_CG42525 | CG42525 gene product from transcript CG42525-RB |
Escherichia coli | b1978 | putative adhesin |
Echinococcus granulosus | EgrG_000745400 | protein split ends |
Echinococcus granulosus | EgrG_000417500 | hypothetical protein |
Echinococcus granulosus | EgrG_000555200 | expressed protein |
Entamoeba histolytica | EHI_188000 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000745400 | protein split ends |
Echinococcus multilocularis | EmuJ_000417500 | conserved hypothetical protein |
Echinococcus multilocularis | EmuJ_001105600 | hypothetical protein |
Echinococcus multilocularis | EmuJ_000937900 | expressed protein |
Homo sapiens | 102723856 | flocculation protein FLO11-like |
Homo sapiens | ENSG00000117983 | mucin 5B, oligomeric mucus/gel-forming |
Homo sapiens | ENSG00000169876 | mucin 17, cell surface associated |
Homo sapiens | ENSG00000261272 | mucin 22 |
Homo sapiens | 101930440 | collagen alpha-5(IV) chain-like |
Homo sapiens | 102725024 | mucin-6-like |
Homo sapiens | ENSG00000110799 | von Willebrand factor |
Homo sapiens | 102725014 | collagen alpha-3(IV) chain-like |
Homo sapiens | ENSG00000184956 | mucin 6, oligomeric mucus/gel-forming |
Homo sapiens | ENSG00000165899 | otogelin-like |
Homo sapiens | 283463 | mucin 19, oligomeric |
Homo sapiens | ENSG00000197558 | SCO-spondin |
Homo sapiens | ENSG00000181143 | mucin 16, cell surface associated |
Homo sapiens | ENSG00000205277 | mucin 12, cell surface associated |
Homo sapiens | 4583 | mucin 2, oligomeric mucus/gel-forming |
Homo sapiens | ENSG00000215182 | mucin 5AC, oligomeric mucus/gel-forming |
Homo sapiens | ENSG00000145113 | mucin 4, cell surface associated |
Homo sapiens | ENSG00000188162 | otogelin |
Leishmania braziliensis | LbrM.34.0530 | proteophosphoglycan ppg4 |
Leishmania braziliensis | LbrM.34.0520 | proteophosphoglycan ppg3, putative |
Leishmania braziliensis | LbrM.34.0540 | proteophosphoglycan ppg4 |
Leishmania braziliensis | LbrM.06.1290 | hypothetical protein, PPG |
Leishmania braziliensis | LbrM.34.0550 | proteophosphoglycan ppg3, putative |
Leishmania donovani | LdBPK_060810.1 | hypothetical protein, unknown function |
Leishmania infantum | LinJ.35.0540 | proteophosphoglycan 5 |
Leishmania infantum | LinJ.35.0500 | proteophosphoglycan ppg3, putative |
Leishmania infantum | LinJ.06.0810 | hypothetical protein, unknown function |
Leishmania infantum | LinJ.35.0530 | proteophosphoglycan 5 |
Leishmania infantum | LinJ.35.0520 | proteophosphoglycan ppg4 |
Leishmania infantum | LinJ.35.0510 | proteophosphoglycan ppg4 |
Leishmania infantum | LinJ.35.0490 | proteophosphoglycan ppg4 |
Leishmania infantum | LinJ.35.0550 | proteophosphoglycan ppg1 |
Leishmania major | LmjF.35.0520 | proteophosphoglycan ppg4 |
Leishmania major | LmjF.35.0500 | proteophosphoglycan ppg3, putative |
Leishmania major | LmjF.35.0540 | proteophosphoglycan 5 |
Leishmania major | LmjF.06.0780 | hypothetical protein, unknown function |
Leishmania major | LmjF.35.0550 | proteophosphoglycan ppg1 |
Leishmania mexicana | LmxM.34.0540 | |
Leishmania mexicana | LmxM.34.0500a | |
Leishmania mexicana | LmxM.34.0500 | proteophosphoglycan ppg3, putative |
Leishmania mexicana | LmxM.34.0550 | proteophosphoglycan ppg1 |
Loa Loa (eye worm) | LOAG_05397 | hypothetical protein |
Loa Loa (eye worm) | LOAG_02844 | hypothetical protein |
Loa Loa (eye worm) | LOAG_02211 | hypothetical protein |
Loa Loa (eye worm) | LOAG_03163 | hypothetical protein |
Loa Loa (eye worm) | LOAG_03162 | hypothetical protein |
Mus musculus | ENSMUSG00000079620 | mucin 4 |
Mus musculus | 102633933 | predicted gene, 31635 |
Mus musculus | 78672 | RIKEN cDNA 9530057J20 gene |
Mus musculus | 17831 | mucin 2 |
Mus musculus | ENSMUSG00000001930 | Von Willebrand factor homolog |
Mus musculus | ENSMUSG00000066108 | mucin 5, subtype B, tracheobronchial |
Mus musculus | 102636358 | predicted gene, 33446 |
Mus musculus | ENSMUSG00000091455 | otogelin-like |
Mus musculus | 102642957 | uncharacterized LOC102642957 |
Mus musculus | 101056219 | uncharacterized LOC101056219 |
Mus musculus | 102642001 | aggrecan core protein-like |
Mus musculus | ENSMUSG00000029797 | SCO-spondin |
Mus musculus | 102633703 | predicted gene, 31464 |
Mus musculus | 239611 | mucin 19 |
Mus musculus | 666185 | predicted gene 7969 |
Mus musculus | 102633718 | predicted gene, 31477 |
Mus musculus | 102633301 | predicted gene, 31160 |
Mus musculus | 102639120 | predicted gene, 35508 |
Mus musculus | ENSMUSG00000009487 | otogelin |
Mus musculus | 101055850 | predicted gene, 29731 |
Mus musculus | ENSMUSG00000037974 | mucin 5, subtypes A and C, tracheobronchial/gastric |
Mus musculus | 102643019 | putative proline-rich protein 21-like |
Mus musculus | ENSMUSG00000048191 | mucin 6, gastric |
Mus musculus | 101055860 | predicted gene, 29734 |
Neospora caninum | NCLIV_010780 | hypothetical protein |
Neospora caninum | NCLIV_012940 | hypothetical protein, conserved |
Neospora caninum | NCLIV_038040 | protein kinase, PfEST homolog, putative |
Oryza sativa | 4352173 | Os12g0456400 |
Oryza sativa | 4330178 | Os02g0653200 |
Oryza sativa | 4347693 | Os09g0535200 |
Onchocerca volvulus | OVOC10258 |
|
Plasmodium falciparum | PF3D7_0501400 | interspersed repeat antigen |
Plasmodium yoelii | PY06855 | Drosophila melanogaster CG5228 gene product |
Saccharomyces cerevisiae | YGR014W | Msb2p |
Saccharomyces cerevisiae | YAL063C | Flo9p |
Saccharomyces cerevisiae | YAR050W | Flo1p |
Saccharomyces cerevisiae | YIL169C | hypothetical protein |
Saccharomyces cerevisiae | YDL039C | Prm7p |
Saccharomyces cerevisiae | YDR420W | Hkr1p |
Saccharomyces cerevisiae | YCR089W | Fig2p |
Saccharomyces cerevisiae | YMR317W | hypothetical protein |
Saccharomyces cerevisiae | YHR211W | Flo5p |
Saccharomyces cerevisiae | YOL155C | Hpf1p |
Saccharomyces cerevisiae | YIR019C | Flo11p |
Schistosoma japonicum | Sjp_0099630 | expressed protein |
Schistosoma japonicum | Sjp_0057190 | Protein split ends, putative |
Schistosoma japonicum | Sjp_0125370 | Mucin-16, putative |
Schistosoma mansoni | Smp_159350 | platelet binding protein-related |
Schmidtea mediterranea | mk4.021208.00 | |
Schmidtea mediterranea | mk4.000308.02 | |
Schmidtea mediterranea | mk4.015403.00 | |
Schmidtea mediterranea | mk4.000911.03 | |
Schmidtea mediterranea | mk4.000308.03 | |
Schmidtea mediterranea | mk4.004800.00 | |
Schmidtea mediterranea | mk4.000191.16 | |
Schmidtea mediterranea | mk4.000911.04 | |
Schmidtea mediterranea | mk4.002886.02 | Platelet binding protein-related |
Schmidtea mediterranea | mk4.000191.12 | |
Schmidtea mediterranea | mk4.001252.02 | |
Schmidtea mediterranea | mk4.000191.11 | |
Trypanosoma brucei gambiense | Tbg972.10.19230 | |
Trypanosoma brucei gambiense | Tbg972.10.19140 | |
Trypanosoma brucei | Tb11.1200 | hypothetical protein |
Trypanosoma brucei | Tb927.9.2080 | invariant surface glycoprotein 100, point mutation |
Trypanosoma brucei | Tb11.1190 | hypothetical protein |
Trypanosoma brucei | Tb927.10.15700 | hypothetical protein, conserved |
Toxoplasma gondii | TGME49_268010 | hypothetical protein |
Toxoplasma gondii | TGME49_212810 | hypothetical protein |
Toxoplasma gondii | TGME49_306390 | hypothetical protein |
Toxoplasma gondii | TGME49_239270 | hypothetical protein |
Theileria parva | TP02_0503 | hypothetical protein |
Trichomonas vaginalis | TVAG_097910 | nuclear anchorage protein, putative |
Trichomonas vaginalis | TVAG_032240 | conserved hypothetical protein |
Trichomonas vaginalis | TVAG_098350 | conserved hypothetical protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.10.15700 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.10.15700 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.10.15700 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.10.15700 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
b1978 | Escherichia coli | non-essential | goodall |
YDR420W | Saccharomyces cerevisiae | inviable | yeastgenome |
TGME49_212810 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_239270 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_306390 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_268010 | Toxoplasma gondii | Essentiality uncertain | sidik |
TGME49_212810 | Toxoplasma gondii | Probably essential | sidik |
TGME49_239270 | Toxoplasma gondii | Probably essential | sidik |
TGME49_306390 | Toxoplasma gondii | Probably essential | sidik |
TGME49_268010 | Toxoplasma gondii | Probably essential | sidik |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Druggability index (range: 0 to 1): 0.3